Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Senior Vice President sold 600 shares at $10.19 ($6,114)
  5. 4 Open-market sale Senior Vice President sold 650 shares at $10.82 ($7,036)
  6. 4 Open-market sale Senior Vice President sold 600 shares at $11.00 ($6,600)
  7. 4 Open-market sale Senior Vice President sold 600 shares at $10.00 ($6,000)
  8. 4 Open-market buy President and CEO bought 50,000 shares at an average $9.51 ($475,354)
  9. 4 Open-market sale Senior Vice President sold 600 shares at $10.00 ($6,000)
  10. 4 Open-market sale Senior Vice President sold 600 shares at $10.63 ($6,378)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Senior Vice President sold 1,200 shares at $11.09 ($13,308)
  18. 4 Open-market sale Senior Vice President sold 1,200 shares at $11.30 ($13,560)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 6 of 15 · 287 filings